The much-anticipated publication “ Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A” has been officially published. This groundbreaking work brings new insights on immunogenicity with data from 6 clinical studies from a cohort of 360 patients with severe Hemophilia A.
Scientists of the Institute Krems Bioanalytics played a crucial role in the development of this publication, contributing their expertise in analytical tests that underpin many of the key findings presented in the paper.
We are proud to have collaborated with Takeda on this important publication and to provide our expertise in bioanalytical tests which provided critical data that helped shape the conclusions of this study.
“ Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A“ is now available:
Blood Advances, Volume 8, Issue 11, 11 June 2024, Pages 2726-2739. https://doi.org/10.1182/bloodadvances.2023011780.